Cargando…
COVID‐19 and diabetes: Is there enough evidence?
The pandemic of COVID‐19, a disease caused by a novel coronavirus SARS‐CoV‐2, is associated with significant morbidity and mortality. Recent data showed that hypertension, diabetes mellitus, cardiovascular diseases, and chronic obstructive pulmonary disease were the most prevalent comorbidities in C...
Autores principales: | Tadic, Marijana, Cuspidi, Cesare, Sala, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300807/ https://www.ncbi.nlm.nih.gov/pubmed/32472662 http://dx.doi.org/10.1111/jch.13912 |
Ejemplares similares
-
Targeting White Coat Hypertension: Is the Daytime Enough?
por: Cuspidi, Cesare, et al.
Publicado: (2020) -
Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
por: Cuspidi, Cesare, et al.
Publicado: (2022) -
COVID‐19 and arterial hypertension: Hypothesis or evidence?
por: Tadic, Marijana, et al.
Publicado: (2020) -
The influence of diabetes and hypertension on outcome in COVID‐19 patients: Do we mix apples and oranges?
por: Tadic, Marijana, et al.
Publicado: (2020) -
Resistant hypertension and COVID-19: tip of the iceberg?
por: Tadic, Marijana, et al.
Publicado: (2021)